I am a hematologic oncologist specializing in treatment of lymphomas.
My research interests involve clinical trials and translational studies in indolent and aggressive lymphomas, as well as health outcome research in hematologic malignancies using registry and administrative databases (SEER-Medicare, NCDB). I am particularly interested in evaluation of treatment interventions using secondary data, while overcoming the inherent bias of such analyses related to their retrospective nature and limited clinical validation.
| Castillo JJ, Guerrero-Garcia T, Baldini F, Tchernonog E, Cartron G, Ninkovic S, Cwynarski K, Dierickx D, Tousseyn T, Lansigan F, Linnik Y, Mogollon R, Navarro JT, Olszewski AJ, Reagan JL, Fedele P, Gilbertson M, Grigoriadis G, Bibas M. "Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma." British Journal of Haematology, vol. 184, no. 4, 2019, pp. 679-682. |
| Olszewski AJ, Chorzalska AD, Kim AS, Quesenberry PJ, Lopresti ML, Fenton MA, Reagan JL, Butera JN, Sahin I, Hamel C, Robison J, Petersen M, Dubielecka PM. "Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy." British Journal of Haematology, vol. 186, no. 3, 2019, pp. e31-e35. |
| Ollila TA, Sahin I, Olszewski AJ. "Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma." OncoTargets and therapy, vol. 12, 2019, pp. 1085-1094. |
| Barth P, Castillo JJ, Olszewski AJ. "Outcomes of secondary solid tumor malignancies among patients with myeloma: A population-based study." Cancer, vol. 125, no. 4, 2019, pp. 550-558. |
| Ollila TA, Olszewski AJ. "Radiation therapy in primary testicular lymphoma: does practice match the standard of care?." Leukemia & lymphoma, vol. 60, no. 2, 2019, pp. 523-526. |
| Chorzalska A, Morgan J, Ahsan N, Treaba DO, Olszewski AJ, Petersen M, Kingston N, Cheng Y, Lombardo K, Schorl C, Yu X, Zini R, Pacilli A, Tepper A, Coburn J, Hryniewicz-Jankowska A, Zhao TC, Oancea E, Reagan JL, Liang O, Kotula L, Quesenberry PJ, Gruppuso PA, Manfredini R, Vannucchi AM, Dubielecka PM. "Bone marrow-specific loss of <i>ABI1</i> induces myeloproliferative neoplasm with features resembling human myelofibrosis." Blood, vol. 132, no. 19, 2018, pp. 2053-2066. |
| Ollila TA, Olszewski AJ. "Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence." Current treatment options in oncology, vol. 19, no. 8, 2018, pp. 38. |
| Ollila TA, Olszewski AJ, Butera JN, Quesenberry MI, Quesenberry PJ, Reagan JL. "Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease." Clinical lymphoma, myeloma & leukemia, vol. 18, no. 3, 2018, pp. 204-209. |
| Chorzalska A, Ahsan N, Rao RSP, Roder K, Yu X, Morgan J, Tepper A, Hines S, Zhang P, Treaba DO, Zhao TC, Olszewski AJ, Reagan J, Liang O, Gruppuso PA, Dubielecka PM. "Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia." Molecular oncology, vol. 12, no. 5, 2018, pp. 630-647. |
| Olszewski AJ, Dusetzina SB, Trivedi AN, Davidoff AJ. "Prescription Drug Coverage and Outcomes of Myeloma Therapy Among Medicare Beneficiaries." Journal of Clinical Oncology, vol. 36, no. 28, 2018, pp. 2879-2886. |
| Olszewski AJ, Ollila T, Reagan JL. "Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas." British Journal of Haematology, vol. 181, no. 4, 2018, pp. 495-504. |
| LeBlanc TW, Egan PC, Olszewski AJ. "Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia." Blood, 2018. |
| Olszewski AJ, Zullo AR, Nering CR, Huynh JP. "Use of Charity Financial Assistance for Novel Oral Anticancer Agents." Journal of Oncology Practice, vol. 14, no. 4, 2018, pp. e221-e228. |
| Olszewski AJ. "Blunt tools, burning questions: using cancer registry data to study relapsed/refractory lymphoma." Leukemia & lymphoma, vol. 58, no. 5, 2017, pp. 1013-1015. |
| Olszewski, Adam J., Chen, Chang, Gutman, Roee, Treon, Steven P., Castillo, Jorge J. "Comparative outcomes of immunochemotherapy regimens in Waldenström macroglobulinaemia." British Journal of Haematology, vol. 179, no. 1, 2017, pp. 106-115. |
| Schumacher A, Sikov WM, Quesenberry MI, Safran H, Khurshid H, Mitchell KM, Olszewski AJ. "Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study." PLoS ONE, vol. 12, no. 2, 2017, pp. e0172957. |
| Olszewski AJ, Reagan JL, Castillo JJ. "Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas." American Journal of Hematology, 2017. |
| Chorzalska A, Kim JF, Roder K, Tepper A, Ahsan N, Rao RSP, Olszewski AJ, Yu X, Terentyev D, Morgan J, Treaba DO, Zhao TC, Liang O, Gruppuso PA, Dubielecka PM. "Long-term exposure to imatinib mesylate downregulates Hippo pathway and activates YAP in a model of chronic myelogenous leukemia." Stem Cells and Development, vol. 26, no. 9, 2017, pp. 656-677. |
| Landsburg DJ, Falkiewicz MK, Maly J, Blum KA, Howlett C, Feldman T, Mato AR, Hill BT, Li S, Medeiros LJ, Torka P, Hernandez-Ilizaliturri F, Reddy NM, Singavi A, Fenske TS, Chavez JC, Kaplan JB, Behdad A, Petrich AM, Bast MA, Vose JM, Olszewski AJ, Costa C, Lansigan F, Gerson JN, Barta SK, Calzada O, Cohen JB, Lue JK, Amengual JE, Rivera X, Persky DO, Peace DJ, Nathan S, Cassaday RD. "Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission." Journal of Clinical Oncology, vol. 35, no. 20, 2017, pp. 2260-2267. |
| Olszewski AJ, Dusetzina SB, Eaton CB, Davidoff AJ, Trivedi AN. "Subsidies for Oral Chemotherapy and Use of Immunomodulatory Drugs Among Medicare Beneficiaries With Myeloma." Journal of Clinical Oncology, vol. 35, no. 29, 2017, pp. 3306-3314. |
| Qunaj L, Castillo JJ, Olszewski AJ. "Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base." Leukemia & lymphoma, 2017, pp. 1-9. |
| Mantripragada KC, Hamid F, Shafqat H, Olszewski AJ. "Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data Base." JNCI Journal of the National Cancer Institute, vol. 109, no. 2, 2016. |
| Migdady Y, Salhab M, Dang NH, Markham MJ, Olszewski AJ. "Disparities in conditional net survival among non-Hodgkin lymphoma survivors: a population-based analysis." Leukemia & lymphoma, vol. 57, no. 3, 2016, pp. 676-84. |
| Olszewski AJ, Treon SP, Castillo JJ. "Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis." The oncologist, 2016. |
| Olszewski AJ. "Formulating a novel prognostic index for diffuse large B-cell lymphoma: T cells break the SILence." Leukemia & lymphoma, vol. 57, no. 12, 2016, pp. 2733-2735. |
| Olszewski AJ, Fallah J, Castillo JJ. "Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base." Cancer, 2016. |
| Olszewski AJ, Gutman R, Eaton CB. "Increased risk of axial fractures in patients with untreated chronic lymphocytic leukemia: a population-based analysis." Haematologica, vol. 101, no. 12, 2016, pp. e488-e491. |
| Olszewski AJ, Castillo JJ. "Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy: analysis of the National Cancer Data Base." AIDS, 2016. |
| Mantripragada KC, Olszewski AJ, Schumacher A, Perez K, Birnbaum A, Reagan JL, Mega A, Khurshid H, Bartley C, Lombardo A, Rossiter R, Papa A, Bakalarski P, Safran H, Mantripragada KC, Olszewski AJ, Schumacher A, Perez K, Birnbaum A, Reagan JL, Mega A, Khurshid H, Bartley C, Lombardo A, Rossiter R, Papa A, Bakalarski P, Safran H. "ReCAP: Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program." Journal of Oncology Practice, 2016. |
| Olszewski AJ, Mantripragada KC, Castillo JJ. "Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma." Journal of the National Comprehensive Cancer Network : JNCCN, vol. 14, no. 9, 2016, pp. 1121-9. |
| Olszewski AJ, Falah J, Castillo JJ. "Survival Claims From Observational Data on Cancer Therapy." Journal of Clinical Oncology, 2016. |
| Fallah J, Olszewski AJ. "Variation in the use of up-front chemotherapy for indolent B-cell lymphomas and chronic lymphocytic leukemia." Hematological oncology, 2016. |
| Olszewski AJ, Ali S, Witherby SM. "Disparate survival trends in histologic subtypes of metastatic non-small cell lung cancer: a population-based analysis." American journal of cancer research, vol. 5, no. 7, 2015, pp. 2229-40. |
| Olszewski AJ, Foran JM. "Health Insurance-Related Disparities in Lymphoma Survival Are Partly Mediated by Baseline Clinical Factors." The oncologist, vol. 20, no. 10, 2015, pp. 1223-4. |
| Castillo JJ, Olszewski AJ, Hunter ZR, Kanan S, Meid K, Treon SP. "Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database." Cancer, vol. 121, no. 13, 2015, pp. 2230-6. |
| Olszewski AJ. "Limits of registry data to understand survival disparities in lymphoma." The Lancet. Haematology, vol. 2, no. 11, 2015, pp. e459-60. |
| Castillo JJ, Olszewski AJ, Kanan S, Meid K, Hunter ZR, Treon SP. "Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database." British Journal of Haematology, vol. 169, no. 1, 2015, pp. 81-9. |
| Olszewski AJ, Shrestha R, Cook NM. "Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base." Cancer, vol. 121, no. 19, 2015, pp. 3472-80. |
| Fallah, Jaleh, Afari, Maxwell Eyram, Cordova, Alfredo C., Olszewski, Adam J., Minami, Taro. "Small Bowel Adenocarcinoma as the Cause of Gastrointestinal Bleeding in Celiac Disease: A Rare Malignancy in a Common Disease." Case Reports in Oncological Medicine, vol. 2015, 2015, pp. 1-5. |
| Khan H, Khan N, Ahmad A, Olszewski AJ, Somasundar P. "Surgical management of metastatic colon cancer: A population-based analysis." Journal of geriatric oncology, vol. 6, no. 6, 2015, pp. 446-53. |
| Shafqat H, Ali S, Salhab M, Olszewski AJ. "Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis." Diseases of the Colon & Rectum, vol. 58, no. 3, 2015, pp. 294-303. |
| Castillo JJ, Olszewski AJ, Kanan S, Meid K, Hunter ZR, Treon SP. "Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database." American Journal of Hematology, vol. 90, no. 8, 2015, pp. 696-701. |
| Olszewski AJ, Shrestha R, Castillo JJ. "Treatment Selection and Outcomes in Early-Stage Classical Hodgkin Lymphoma: Analysis of the National Cancer Data Base." Journal of Clinical Oncology, vol. 33, no. 6, 2015, pp. 625-33. |
| Olszewski AJ, Winer ES, Castillo JJ. "Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base." Cancer Causes & Control, vol. 26, no. 8, 2015, pp. 1163-72. |
| Shafqat H, Olszewski AJ. "Chlorambucil-induced acute interstitial pneumonitis." Case reports in hematology, vol. 2014, 2014, pp. 575417. |
| Olszewski AJ, Ali S. "Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma." Annals of hematology, vol. 93, no. 3, 2014, pp. 449-58. |
| Ali S, Olszewski AJ. "Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study." Leukemia & lymphoma, vol. 55, no. 7, 2014, pp. 1570-7. |
| Olszewski AJ, Shafqat H, Ali S. "Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma." Leukemia & lymphoma, 2014, pp. 1-19. |
| Bishop KD, Olszewski AJ. "Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis." International Journal of Cancer, vol. 134, no. 12, 2014, pp. 2961-71. |
| Olszewski AJ, Winer ES, Castillo JJ. "Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma." Leukemia Research, vol. 38, no. 8, 2014, pp. 866-73. |
| Chorzalska A, Salloum I, Shafqat H, Khan S, Marjon P, Treaba D, Schorl C, Morgan J, Bryke CR, Falanga V, Zhao TC, Reagan J, Winer E, Olszewski AJ, Al-Homsi AS, Kouttab N, Dubielecka PM. "Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia." Leukemia, vol. 28, no. 11, 2014, pp. 2165-77. |
| Khan H, Olszewski AJ, Somasundar P. "Lymph node involvement in colon cancer patients decreases with age; a population based analysis." European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, vol. 40, no. 11, 2014, pp. 1474-80. |
| Olszewski AJ, Desai A. "Radiation therapy administration and survival in stage I/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue." International Journal of Radiation Oncology*Biology*Physics, vol. 88, no. 3, 2014, pp. 642-9. |
| Shafqat H, Alquadan KF, Olszewski AJ. "Severe hypocalcemia after denosumab in a patient with acquired Fanconi syndrome." Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol. 25, no. 3, 2014, pp. 1187-90. |
| Castillo JJ, Winer ES, Olszewski AJ. "Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database." American Journal of Hematology, vol. 89, no. 3, 2014, pp. 310-4. |
| Castillo JJ, Olszewski AJ, Cronin AM, Hunter ZR, Treon SP. "Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database." Blood, vol. 123, no. 25, 2014, pp. 3999-4000. |
| Migdady Y, Sakr BJ, Sikov WM, Olszewski AJ. "Adjuvant chemotherapy in T1a/bN0 HER2-positive or triple-negative breast cancers: application and outcomes." Breast (Edinburgh, Scotland), vol. 22, no. 5, 2013, pp. 793-8. |
| Olszewski AJ, Castillo JJ. "Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database." Annals of Oncology, vol. 24, no. 5, 2013, pp. 1352-9. |
| Olszewski AJ, Migdady Y, Boolbol SK, Klein P, Boachie-Adjei K, Sakr BJ, Sikov W, Shao T. "Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective study." Breast cancer research and treatment, vol. 138, no. 1, 2013, pp. 215-23. |
| Migdady Y, Olszewski AJ. "Evaluation of incidental neutropenia in a multi-ethnic setting." International journal of laboratory hematology, vol. 35, no. 1, 2013, pp. e6-8. |
| Olszewski AJ. "Evaluation of the physician-patient communication assessment tool (CAT) in a hematology-oncology practice." Journal of Clinical Oncology, vol. 31, no. 31_suppl, 2013, pp. 14. |
| Olszewski AJ, Grossbard ML, Chung MS, Chalasani SB, Malamud S, Mirzoyev T, Kozuch PS. "Phase I study of oxaliplatin in combination with gemcitabine, irinotecan, and 5-fluorouracil/leucovorin (G-FLIE) in patients with metastatic solid tumors including adenocarcinoma of the pancreas." Journal of gastrointestinal cancer, vol. 44, no. 2, 2013, pp. 182-9. |
| Castillo JJ, Winer ES, Olszewski AJ. "Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database." Cancer, vol. 119, no. 20, 2013, pp. 3672-9. |
| Desai A, Telang GH, Olszewski AJ. "Remission of primary cutaneous anaplastic large cell lymphoma after a brief course of brentuximab vedotin." Annals of hematology, vol. 92, no. 4, 2013, pp. 567-8. |
| Olszewski AJ, Castillo JJ. "Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database." Cancer, vol. 119, no. 3, 2013, pp. 629-38. |
| Gavini A, Telang GH, Olszewski AJ. "Generalized purpuric drug exanthem with hemorrhagic plaques following bendamustine chemotherapy in a patient with B-prolymphocytic leukemia." International journal of hematology, vol. 95, no. 3, 2012, pp. 311-4. |
| Casey DJ, Kim AY, Olszewski AJ. "Progressive pericardial effusion during chemotherapy for advanced Hodgkin lymphoma." American Journal of Hematology, vol. 87, no. 5, 2012, pp. 521-4. |
| Olszewski AJ. "Survival outcomes with and without splenectomy in splenic marginal zone lymphoma." American Journal of Hematology, vol. 87, no. 11, 2012, pp. E119-22. |
| Migdady Y, Olszewski AJ. "Paroxysmal nocturnal hemoglobinuria presenting with a left intraventricular thrombus in a patient with prior thymoma and aplastic anemia." Clinical Medicine Insights. Oncology, vol. 5, 2011, pp. 343-8. |
| Olszewski AJ, Grossbard ML. "Empowering targeted therapy: lessons from rituximab." Science's STKE : signal transduction knowledge environment, vol. 2004, no. 241, 2004, pp. pe30. |
| Li M, Ona VO, Guégan C, Chen M, Jackson-Lewis V, Andrews LJ, Olszewski AJ, Stieg PE, Lee JP, Przedborski S, Friedlander RM. "Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model." Science, vol. 288, no. 5464, 2000, pp. 335-9. |
05/2015-06/2016: Rhode Island Foundation Medical Research Grant
07/2015-06/2017: Junior Faculty Scholar Award, American Society of Hematology
04/2016-03/2019: Research Scholar Grant, American Cancer Society
07/2017-06/2018: IDeA-CTR grant, National Institute of General Medical Science
| Year | Degree | Institution |
|---|---|---|
| 1999 | MD | University of Warsaw |
American Cancer Society Research Scholar Award, 2015
Alpha Omega Alpha, member
Dean's Excellence in Teaching Award, Alpert Medical School of Brown University, 2015
2015 Beckwith Family Teaching Award for outstanding teaching, Alpert Medical School of Brown University, 2015
American Society of Hematology Scholar Award; 2015
Teaching Achievement Award, Internal Medicine Residency Program, Memorial Hospital of Rhode Island, 2014
Chief Fellow Appointment, St. Luke's-Roosevelt Hospital Center, New York, 2005
Award for Outstanding Excellence in Primary Care, St. Luke's-Roosevelt Hospital Center, New York, 2003
W.I.S.E. (Worldwide Insitute Supporting Exchange) Scholarship, Worcester, MA, 2000
Academic Proficiency Award, years 2 through 6, The Medical University of Warsaw, Poland, 1994-1999
| Name | Title |
|---|---|
| Belanger, Emmanuelle | Assistant Professor of Health Services, Policy and Practice |
| Butera, James | Clinical Associate Professor of Medicine |
| Dahabreh, Issa | Adjunct Associate Professor of Epidemiology |
| Dubielecka-Szczerba, Patrycja | Associate Professor of Medicine |
| Gutman, Roee | Associate Professor of Biostatistics |
| Panagiotou, Orestis | Assistant Professor of Health Services, Policy and Practice (Research) |
| Patel, Nimesh | Assistant Professor of Pathology and Laboratory Medicine |
| Quesenberry, Peter | Paul Calabresi, M.D. Professor of Oncology, Professor of Medicine |
| Reagan, John | Associate Professor of Medicine |
| Safran, Howard | Professor of Medicine |
| Sakr, Bachir | Assistant Professor of Medicine, Clinician Educator, Assistant Professor of Obstetrics and Gynecology, Clinician Educator |
| Trivedi, Amal | Professor of Health Services, Policy and Practice, Professor of Medicine |
| Zullo, Andrew | Assistant Professor of Health Services, Policy and Practice, Assistant Professor of Epidemiology |
